AU2015242879A1 - Melatonin secretion regulator, and method for regulating melatonin secretion - Google Patents
Melatonin secretion regulator, and method for regulating melatonin secretionInfo
- Publication number
- AU2015242879A1 AU2015242879A1 AU2015242879A AU2015242879A AU2015242879A1 AU 2015242879 A1 AU2015242879 A1 AU 2015242879A1 AU 2015242879 A AU2015242879 A AU 2015242879A AU 2015242879 A AU2015242879 A AU 2015242879A AU 2015242879 A1 AU2015242879 A1 AU 2015242879A1
- Authority
- AU
- Australia
- Prior art keywords
- melatonin secretion
- regulating
- regulator
- melatonin
- secretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title abstract 5
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title abstract 5
- 229960003987 melatonin Drugs 0.000 title abstract 5
- 230000028327 secretion Effects 0.000 title abstract 5
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Abstract
The problem of the present invention is to provide a melatonin secretion regulator capable of regulating melatonin secretion in vivo; this problem is solved by providing a melatonin secretion regulator containing ornithine or a salt thereof as an active ingredient.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014072675 | 2014-03-31 | ||
| JP2014-072675 | 2014-03-31 | ||
| PCT/JP2015/060283 WO2015152311A1 (en) | 2014-03-31 | 2015-03-31 | Melatonin secretion regulator, and method for regulating melatonin secretion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015242879A1 true AU2015242879A1 (en) | 2016-10-20 |
| AU2015242879A8 AU2015242879A8 (en) | 2016-11-10 |
Family
ID=54240629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015242879A Abandoned AU2015242879A1 (en) | 2014-03-31 | 2015-03-31 | Melatonin secretion regulator, and method for regulating melatonin secretion |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6594858B2 (en) |
| CN (1) | CN106163510A (en) |
| AU (1) | AU2015242879A1 (en) |
| SG (1) | SG11201608082XA (en) |
| WO (1) | WO2015152311A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019182775A (en) * | 2018-04-09 | 2019-10-24 | キリンホールディングス株式会社 | Compositions for promoting delayed melatonin secretion onset time, compositions for improving early wakening and compositions for improving advanced circadian rhythm phase |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5053535B2 (en) * | 2005-05-13 | 2012-10-17 | 協和発酵バイオ株式会社 | Oral for improving sleep or waking up |
| JP5649265B2 (en) * | 2006-07-27 | 2015-01-07 | 江崎グリコ株式会社 | Sleep improver |
-
2015
- 2015-03-31 JP JP2016511972A patent/JP6594858B2/en active Active
- 2015-03-31 AU AU2015242879A patent/AU2015242879A1/en not_active Abandoned
- 2015-03-31 CN CN201580018289.2A patent/CN106163510A/en active Pending
- 2015-03-31 SG SG11201608082XA patent/SG11201608082XA/en unknown
- 2015-03-31 WO PCT/JP2015/060283 patent/WO2015152311A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015242879A8 (en) | 2016-11-10 |
| SG11201608082XA (en) | 2016-11-29 |
| JP6594858B2 (en) | 2019-10-23 |
| WO2015152311A1 (en) | 2015-10-08 |
| CN106163510A (en) | 2016-11-23 |
| JPWO2015152311A1 (en) | 2017-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017013562A (en) | Microbiome regulators and related uses thereof. | |
| MX2017003516A (en) | Pyrazole derivatives as sgc stimulators. | |
| EP4282479A3 (en) | Use of pridopidine to treat depression or anxiety | |
| SG10201809457YA (en) | Insulin receptor partial agonists | |
| SG10201810879VA (en) | Pharmaceutical compounds | |
| EP4268860A3 (en) | Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue | |
| MX2021015102A (en) | Colony stimulating factor-1 receptor (csf-1r) inhibitors. | |
| EP3316890A4 (en) | Novel breathing control modulating compounds, and methods of making and using same | |
| PH12017500533A1 (en) | 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
| TW201612319A (en) | Microorganism producing O-phosphoserine and a method for producing O-phosphoserine or L-cysteine using the same | |
| EP3263119A4 (en) | Composition including extracellular vesicles derived from bacteria of bacillus sp. for treating pregnancy-associated diseases | |
| WO2014145897A3 (en) | Immunotherapy system and method thereof | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| SA517390475B1 (en) | System of Multiple Bags and Method for The Preparation of Hemocomponents | |
| MX2016004325A (en) | Novel derivative of an insulin analogue. | |
| ZA201703467B (en) | Methods of treating ocular conditions | |
| SG10201908248PA (en) | Processes for preparing fluoroketolides | |
| MX2018002726A (en) | Method for producing cyanohydrin esters containing phosphorous. | |
| MX2017008090A (en) | Novel compounds, synthesis method thereof and use of same in medicine and in cosmetics. | |
| AU2015242879A1 (en) | Melatonin secretion regulator, and method for regulating melatonin secretion | |
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| MY195763A (en) | A Herbicidal Composition and Process Thereof | |
| MY183051A (en) | Composition containing material for regulating expression of abh antigens | |
| MX2016017141A (en) | Crystal of allisartan isoproxil, preparation method therefor and pharmaceutical composition containing same. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH | Corrigenda |
Free format text: IN VOL 30 , NO 42 , PAGE(S) 6165 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, APPLICATION NO. 2015242879, UNDER INID (71) ADD CO-APPLICANT KYOWA HAKKO BIO CO., LTD. |
|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |